mRNA Covid vaccines spark immune response that may aid cancer survival
a day ago
- #immune checkpoint inhibitors
- #mRNA vaccines
- #cancer immunotherapy
- mRNA COVID-19 vaccines may extend the lives of cancer patients by boosting immunotherapy effectiveness.
- A study of nearly 1,000 advanced skin and lung cancer patients showed vaccinated individuals lived nearly twice as long as unvaccinated ones when treated with immune checkpoint inhibitors.
- mRNA vaccines trigger an innate immune response, enhancing T-cell activity against tumors.
- Combining checkpoint inhibitors with mRNA vaccines appears more effective than either treatment alone.
- The findings were presented at the European Society for Medical Oncology Congress, with plans for a clinical trial to confirm results.
- mRNA vaccines may have anti-tumor effects even without checkpoint inhibitors, though further research is needed.
- Funding cuts for mRNA vaccine development in the US could hinder future medical advancements.